Plasma Profiles of Neuroglial Injury Biomarkers after Ischemic StrokeShow others and affiliations
2025 (English)In: Translational Stroke Research, ISSN 1868-4483, E-ISSN 1868-601X, Vol. 16, no 6, p. 2185-2194Article in journal (Refereed) Published
Abstract [en]
OBJECTIVE: To determine the temporal profiles of glial fibrillary acidic protein (GFAP), neurofilament light (NFL), total tau (t-tau), and ubiquitin carboxy-terminal hydrolase L1 (UCHL1) in plasma the first week after acute ischemic stroke, and identify the optimal time points for assessing infarct volume by these biomarkers.
PATIENTS & METHODS: In this cohort study, biomarker plasma concentrations were determined daily over the first week and at 90 days after symptom onset in patients with acute ischemic stroke. A brain MRI was performed on day three. Temporal variations in biomarker levels were analyzed using linear mixed-effects models, and optimal time points for infarct volume correlation were identified with continuous Pearson analysis.
RESULTS: 38 patients with a median age of 78 (IQR 72-86) and mean infarct volume of 5.5 (IQR 1.6-17) cm3 were included. We identified three distinct temporal patterns: (1) a parabolic trajectory of GFAP, reaching zenith after three days, (2) a consistent increase in NFL throughout the week, and (3) an initial surge in t-tau and UCHL1 levels, stabilizing by day three. The optimal time point for infarct volume correlation occurred at 119 h for GFAP (r = 0.94, 95% CI: [0.84-0.98]), 144 h for NFL (r = 0.78, [0.47, 0.92]), 122 h for t-tau (r = 0.82, [0.56, 0.93]) and 113 h for UCHL1 (r = 0.83, [0.60, 0.93]).
INTERPRETATION: This high-resolution serial sampling of plasma GFAP, NFL, t-tau, and UCHL1 the first week after acute ischemic stroke identified three distinct temporal profiles. These biomarkers provided the most accurate infarct volume assessment 4-6 days after symptom onset.
CLINICALTRIALS: gov NCT03812666 (registration date 2019-01-23).
Place, publisher, year, edition, pages
Springer, 2025. Vol. 16, no 6, p. 2185-2194
Keywords [en]
Glial fibrillary acidic protein, Neurofilament, Stroke, Tau, Ubiquitin carboxy-terminal hydrolase L1
National Category
Neurosciences
Identifiers
URN: urn:nbn:se:oru:diva-123404DOI: 10.1007/s12975-025-01380-yISI: 001562507300001PubMedID: 40900222Scopus ID: 2-s2.0-105015100681OAI: oai:DiVA.org:oru-123404DiVA, id: diva2:1995349
Funder
Uppsala UniversityNyckelfonden
Note
Funding Agencies:
Open access funding provided by Uppsala University. This work was supported by the Regional Research Council Mid Sweden, the Bissen Brainwalk Foundation, Nyckelfonden – Örebro University Hospital Research Foundation, the Research Committee at Örebro University Hospital, and Swedish state support for research (ALF agreement).
2025-09-052025-09-052026-01-23Bibliographically approved